Trial site
Stanford Cancer Center
- 11running trials
- 16closed trials
The trials here
What the 27 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers5 trials
- Melanoma4 trials
- Acute myeloid leukaemia2 trials
- Bladder cancer2 trials
- Colorectal cancer2 trials
- Diffuse large B-cell lymphoma2 trials
- Follicular lymphoma2 trials
- Lung cancer2 trials
- Myelodysplastic syndromes2 trials
- Sarcoma2 trials
- Chronic myeloid leukaemia1 trial
- Gastric and oesophageal cancer1 trial
- and 8 more
- Phase
- Phase 38 trials
- Phase 16 trials
- Phase 26 trials
- Phase 1/23 trials
- Phase 2/33 trials
- Status
- Completed8 trials
- Terminated8 trials
- Active, not recruiting7 trials
- Recruiting3 trials
- Not yet recruiting1 trial
- Lead sponsor
- Celgene4 trials
- Hoffmann-La Roche3 trials
- Jazz Pharmaceuticals2 trials
- Novartis Pharmaceuticals2 trials
- Aadi Bioscience, Inc.1 trial
- and 15 more
Running trials
Recruiting
Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures
Recruiting
Active, not recruiting
Recruiting
Phase 2 Open Label Randomized Study of Pirtobrutinib and Brexucabtagene Autoleucel in R/R MCL
Active, not recruiting
Active, not recruiting
Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers2 recruiting
- Mantle cell lymphoma1 recruiting
- Melanoma1 recruiting
Closed trials
Recruiting
ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study)
Terminated
A Study of Unesbulin in Participants With Advanced Leiomyosarcoma (LMS)
Completed
Terminated
Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors
Recruiting
Terminated
Recruiting
Recruiting
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Terminated
Completed
Terminated
Terminated
Terminated
Completed
Completed
Completed
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
Site data: ClinicalTrials.govUpdated 12 Nov 2026